November 14, 2023 — Deepak Srivastava, MD, president of Gladstone Institutes and a renowned cardiovascular researcher, took the stage on Saturday in Philadelphia to receive the American Heart Association’s Distinguished Scientist award—joining a preeminent group of scientists and clinicians wh

November 14, 2023 — Eko Health, Inc., a leader in AI technology for heart and lung disease detection, today unveiled new clinical data at the 2023 American Heart Association Scientific Sessions.

November 13, 2023 — Visage Imaging, Inc., a wholly owned subsidiary of Pro Medicus Ltd., has announced it will be showcasing a series of exciting new product additions and innovations, as well as the industry-leading Visage 7 Enterprise Imaging Platform ("Visage 7"), engineered for CloudPACS (

November 13, 2023 — Vektor Medical, a pioneer in non-invasive arrhythmia analysis technology, is proud to highlight two studies showcasing vMap’s novel application in the analysis and treatment of ventricular arrhythmias. Both studies are being presented by Dr.

November 13, 2023 — Ultromics, a leading health technology company at the forefront of detection of heart failure and its phenotypes, announces a significant development regarding the reimbursement code for its flagship product, 

November 11, 2023 — Results of a randomized trial presented today at the American Heart Association’s Scientific Sessions 2023 (AHA 2023), which compared the effects of high-sodium and low-sodium diets on blood pressure in adults, found that following a low-sodium diet significantly lowered blood pressure in 70%-

November 10, 2023 —Getinge announced commercial availability of the iCast covered stent system in the United States for the treatment of iliac arterial occlusive disease. In March 2023, the iCast covered stent received premarket approval from the U.S. Food and Drug Administration (FDA) for the treatment of iliac arterial occlusive disease. Lower extremity peripheral artery disease (PAD) is estimated to affect approximately 8.5 million people in the U.S.

November 10, 2023 — Silence Therapeutics plc, an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines, announced positive topline results from the multiple dose component of the APOLLO phase 1 study of z

November 10, 2023 — Cardiologists, cardiothoracic surgeons and interventionalists from the Smidt Heart Institute at Cedars-Sinai will unveil research and clinical insights during the American Heart Association (AHA) Scientific Sessions Nov. 11-13 in Philadelphia. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now